MOLN
Income statement / Annual
Last year (2024), Molecular Partners AG's total revenue was $4.97 M,
a decrease of 29.38% from the previous year.
In 2024, Molecular Partners AG's net income was -$54.04 M.
See Molecular Partners AG,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$4.97 M |
$7.04 M |
$189.56 M |
$9.33 M |
$9.34 M |
$20.38 M |
$10.36 M |
$20.02 M |
$23.04 M |
$29.12 M |
| Cost of Revenue |
$47.50 M
|
$47.84 M
|
$50.75 M
|
$55.72 M
|
$56.08 M
|
$43.50 M
|
$15.60 M
|
$17.82 M
|
$14.57 M
|
$1.17 M
|
| Gross Profit |
-$42.53 M
|
-$40.81 M
|
$138.81 M
|
-$46.39 M
|
-$46.73 M
|
-$23.12 M
|
-$5.25 M
|
$2.19 M
|
$8.47 M
|
$27.95 M
|
| Gross Profit Ratio |
-8.56
|
-5.8
|
0.73
|
-4.97
|
-5
|
-1.13
|
-0.51
|
0.11
|
0.37
|
0.96
|
| Research and Development Expenses |
$48.60 M
|
$48.78 M
|
$50.75 M
|
$55.72 M
|
$56.08 M
|
$43.50 M
|
$38.20 M
|
$37.45 M
|
$35.19 M
|
$23.92 M
|
| General & Administrative Expenses |
$17.16 M
|
$19.00 M
|
$21.82 M
|
$16.91 M
|
$11.03 M
|
$13.16 M
|
$9.46 M
|
$8.28 M
|
$7.24 M
|
$6.22 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$17.16 M
|
$19.00 M
|
$21.82 M
|
$16.91 M
|
$11.03 M
|
$13.16 M
|
$9.46 M
|
$8.28 M
|
$7.24 M
|
$6.22 M
|
| Other Expenses |
-$47.09 M
|
-$47.48 M
|
$372.00 K
|
$125.00 K
|
$568.00 K
|
$381.00 K
|
$100.00 K
|
$126.00 K
|
$103.00 K
|
$1.20 M
|
| Operating Expenses |
$18.68 M
|
$20.30 M
|
$72.94 M
|
$72.75 M
|
$67.67 M
|
$57.04 M
|
$47.77 M
|
$45.86 M
|
$42.53 M
|
$31.34 M
|
| Cost And Expenses |
$66.19 M
|
$68.15 M
|
$72.94 M
|
$72.75 M
|
$67.67 M
|
$57.04 M
|
$47.77 M
|
$45.86 M
|
$42.53 M
|
$31.34 M
|
| Interest Income |
$3.38 M
|
$4.28 M
|
$1.20 M
|
$108.28 K
|
$391.00 K
|
$1.61 M
|
$693.00 K
|
$610.00 K
|
$335.00 K
|
$358.00 K
|
| Interest Expense |
$25.00 K
|
$49.00 K
|
$648.12 K
|
$608.14 K
|
$323.88 K
|
$100.63 K
|
$102.00 K
|
$197.00 K
|
$89.00 K
|
$154.00 K
|
| Depreciation & Amortization |
$2.37 M
|
$2.42 M
|
$2.39 M
|
$2.57 M
|
$2.89 M
|
$2.47 M
|
$924.00 K
|
$1.15 M
|
$1.09 M
|
$909.39 K
|
| EBITDA |
-$51.65 M |
-$59.52 M |
$119.00 M |
-$60.66 M |
-$59.58 M |
-$33.70 M |
-$36.11 M |
-$24.70 M |
-$17.52 M |
$760.00 K |
| EBITDA Ratio |
-10.39
|
-8.46
|
0.63
|
-6.5
|
-6.38
|
-1.65
|
-3.49
|
-1.23
|
-0.76
|
0.03
|
| Operating Income Ratio |
-12.32
|
-8.68
|
0.62
|
-6.8
|
-6.24
|
-1.8
|
-3.61
|
-1.29
|
-0.85
|
-0.08
|
| Total Other Income/Expenses Net |
$7.18 M
|
-$876.00 K
|
$1.24 M
|
-$365.00 K
|
-$4.45 M
|
$389.00 K
|
$374.00 K
|
$414.00 K
|
$874.00 K
|
$2.07 M
|
| Income Before Tax |
-$54.04 M
|
-$61.98 M
|
$117.85 M
|
-$63.78 M
|
-$62.78 M
|
-$36.27 M
|
-$37.04 M
|
-$25.43 M
|
-$18.61 M
|
-$148.82 K
|
| Income Before Tax Ratio |
-10.87
|
-8.81
|
0.62
|
-6.84
|
-6.72
|
-1.78
|
-3.58
|
-1.27
|
-0.81
|
-0.01
|
| Income Tax Expense |
$2.00 K
|
$0.00
|
$0.00
|
$2.00 K
|
-$11.00 K
|
$17.00 K
|
-$156.00 K
|
-$1.00 K
|
$0.00
|
-$1.78 M
|
| Net Income |
-$54.04 M
|
-$61.98 M
|
$117.85 M
|
-$63.79 M
|
-$62.76 M
|
-$36.29 M
|
-$37.04 M
|
-$25.43 M
|
-$18.61 M
|
-$148.82 K
|
| Net Income Ratio |
-10.87
|
-8.81
|
0.62
|
-6.84
|
-6.72
|
-1.78
|
-3.58
|
-1.27
|
-0.81
|
-0.01
|
| EPS |
-1.59 |
-1.89 |
3.63 |
-2.06 |
-2.51 |
-1.69 |
-1.75 |
-1.22 |
-0.91 |
-0.0076 |
| EPS Diluted |
-1.59 |
-1.89 |
3.54 |
-2.06 |
-2.51 |
-1.69 |
-1.75 |
-1.22 |
-0.91 |
-0.0076 |
| Weighted Average Shares Out |
$34.03 M
|
$32.77 M
|
$32.47 M
|
$31.01 M
|
$25.00 M
|
$21.41 M
|
$21.17 M
|
$20.86 M
|
$20.43 M
|
$19.54 M
|
| Weighted Average Shares Out Diluted |
$34.03 M
|
$32.77 M
|
$33.27 M
|
$31.01 M
|
$25.00 M
|
$21.41 M
|
$21.17 M
|
$20.86 M
|
$20.43 M
|
$19.54 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
